Skip to Content
MilliporeSigma
  • Inhibition of HepG2 cell proliferation by ursolic acid and polysaccharides via the downregulation of cyclooxygenase-2.

Inhibition of HepG2 cell proliferation by ursolic acid and polysaccharides via the downregulation of cyclooxygenase-2.

Molecular medicine reports (2014-03-19)
Ling Liu, Jingkai Zhang, Meiling Li, Xiaohong Zhang, Jinlu Zhang, Zhenjing Li, Likui Wang, Jihui Wu, Cheng Luo
ABSTRACT

Cyclooxygenase (COX)-2, a multi-functional molecule, is overexpressed in hepatocellular carcinomas. In order to understand cell proliferation and its association with COX-2 in HepG2 cells in the presence of ursolic acid (UA), viili exopolysaccharides (VEPS) and Astragalus polysaccharides (APS), the cell proliferation, superoxide dismutase (SOD) and metabolic malondialdehyde (MDA) of fatty acids, COX-2, prostaglandin E2 (PGE2), as well as apoptotic morphology and rate were investigated. The results revealed that the activities of SOD, COX-2 and PGE2 were reduced, MDA was markedly decreased, apoptotic blebs were induced, and HepG2 cells were accumulated in the G1 and sub G1/apoptotic phases in test groups. The results indicated that UA, VEPS, APS and any combination of these possess anticancer properties, particularly by downregulating COX-2 expression, which may have increased internal oxidation and triggered apoptosis together with a change in internal antioxidant response elements, leading to a reduction in cell proliferation.

MATERIALS
Product Number
Brand
Product Description

Supelco
Ursolic acid, analytical standard
Pricing and availability is not currently available.
Sigma-Aldrich
Ursolic acid, ≥90%
Pricing and availability is not currently available.
Ursolic acid, European Pharmacopoeia (EP) Reference Standard
Pricing and availability is not currently available.
Ursolic acid, primary reference standard
Pricing and availability is not currently available.